Physician

Wasif Riaz, M.D

According to 2025 Medicare claims, Wasif Riaz, M.D (NPI: 1497929319) practices hematology/oncology in the Sebring, FL market, with the plurality of this provider's patient population coming from Highlands, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 33870-1204.

Riaz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,213 traditional Medicare patients, billed 429,334 HCPCS/CPT codes, and received $7,344,462 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,677 prescription claims across 544 beneficiaries totaling $10,257,191 in drug costs, led by Revlimid (Lenalidomide). 2018 DME data shows 11 claims. Open Payments data shows 235 records totaling $4,843. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $2,152,660 to $7,344,462. Similarly, Part D prescription costs have moved sharply higher in recent years, from $776,233 to $10,257,191. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.7M$7.3M2015 Medicare payment: $2,152,660 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,075,599 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,958,501 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,992,019 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,154,058 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,759,735 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,348,458 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,794,615 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,799,926 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $7,344,462 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015965169,859$2,152,660
20161,006253,451$3,075,599
20171,135286,871$3,958,501
20181,209372,811$4,992,019
20191,152450,409$6,154,058
20201,016374,814$5,759,735
20211,208410,945$6,348,458
20221,148472,192$6,794,615
20231,157474,546$6,799,926
20241,213429,334$7,344,462

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.1M$10M2015 Drug cost: $776,233 (USD; Tot_Drug_Cst)2016 Drug cost: $867,409 (USD; Tot_Drug_Cst)2017 Drug cost: $1,323,769 (USD; Tot_Drug_Cst)2018 Drug cost: $2,886,806 (USD; Tot_Drug_Cst)2019 Drug cost: $3,128,477 (USD; Tot_Drug_Cst)2020 Drug cost: $4,616,689 (USD; Tot_Drug_Cst)2021 Drug cost: $8,081,066 (USD; Tot_Drug_Cst)2022 Drug cost: $9,398,371 (USD; Tot_Drug_Cst)2023 Drug cost: $7,929,700 (USD; Tot_Drug_Cst)2024 Drug cost: $10,257,191 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015175582$776,233
2016234844$867,409
2017248934$1,323,769
20183521,465$2,886,806
20193491,553$3,128,477
20203732,007$4,616,689
20214642,466$8,081,066
20224392,251$9,398,371
20234742,457$7,929,700
20245442,677$10,257,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.5K$9.1K2015 Medicare payment: $7,184 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,063 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $3,840 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R119$7,184
201612168$9,063
2017N/RN/RN/R
2018N/R11$3,840
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7362,255$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more261327$61
96372Injection of drug or substance under skin or into muscle3131,430$10
36415Insertion of needle into vein for collection of blood sample8183,054$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count8363,392$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide2206,097$3,769,955
XtandiEnzalutamide541,620$750,208
IbrancePalbociclib411,148$658,383
PomalystPomalidomide24672$552,413
BrukinsaZanubrutinib29870$428,748

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.235$4,843PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wasif Riaz, M.D?

Tedicare shows public-source Medicare data for Wasif Riaz, M.D (NPI 1497929319), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wasif Riaz, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Wasif Riaz, M.D?

Wasif Riaz, M.D is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Wasif Riaz, M.D have Open Payments data?

Wasif Riaz, M.D has 235 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.